Compare Procter & Gamble Health with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs J.B.CHEMICALS - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH J.B.CHEMICALS PROCTER & GAMBLE HEALTH/
J.B.CHEMICALS
 
P/E (TTM) x 53.3 20.2 263.7% View Chart
P/BV x 4.6 2.8 166.1% View Chart
Dividend Yield % 10.2 0.4 2,426.6%  

Financials

 PROCTER & GAMBLE HEALTH   J.B.CHEMICALS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
J.B.CHEMICALS
Mar-18
PROCTER & GAMBLE HEALTH/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs3,549363 977.4%   
Low Rs1,301255 510.3%   
Sales per share (Unadj.) Rs511.4169.1 302.4%  
Earnings per share (Unadj.) Rs61.316.6 369.2%  
Cash flow per share (Unadj.) Rs74.023.4 316.1%  
Dividends per share (Unadj.) Rs440.002.00 22,000.0%  
Dividend yield (eoy) %18.10.6 2,803.6%  
Book value per share (Unadj.) Rs927.8172.5 537.9%  
Shares outstanding (eoy) m16.6083.57 19.9%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.71.8 259.5%   
Avg P/E ratio x39.618.6 212.5%  
P/CF ratio (eoy) x32.813.2 248.3%  
Price / Book Value ratio x2.61.8 145.9%  
Dividend payout %717.912.0 5,958.4%   
Avg Mkt Cap Rs m40,25725,827 155.9%   
No. of employees `0001.13.8 30.1%   
Total wages/salary Rs m1,3132,511 52.3%   
Avg. sales/employee Rs Th7,486.73,747.4 199.8%   
Avg. wages/employee Rs Th1,157.6665.7 173.9%   
Avg. net profit/employee Rs Th897.2367.8 244.0%   
INCOME DATA
Net Sales Rs m8,49014,135 60.1%  
Other income Rs m244366 66.7%   
Total revenues Rs m8,73414,501 60.2%   
Gross profit Rs m1,4822,178 68.0%  
Depreciation Rs m211570 37.1%   
Interest Rs m035 0.0%   
Profit before tax Rs m1,5141,940 78.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m563552 101.8%   
Profit after tax Rs m1,0171,387 73.3%  
Gross profit margin %17.515.4 113.2%  
Effective tax rate %37.128.5 130.4%   
Net profit margin %12.09.8 122.1%  
BALANCE SHEET DATA
Current assets Rs m15,34310,470 146.5%   
Current liabilities Rs m1,9602,749 71.3%   
Net working cap to sales %157.654.6 288.6%  
Current ratio x7.83.8 205.5%  
Inventory Days Days4955 88.3%  
Debtors Days Days2878 36.6%  
Net fixed assets Rs m1,2095,811 20.8%   
Share capital Rs m166167 99.3%   
"Free" reserves Rs m15,23514,248 106.9%   
Net worth Rs m15,40114,416 106.8%   
Long term debt Rs m00-   
Total assets Rs m17,59517,649 99.7%  
Interest coverage xNM56.6-  
Debt to equity ratio x00-  
Sales to assets ratio x0.50.8 60.2%   
Return on assets %5.88.1 71.8%  
Return on equity %6.69.6 68.6%  
Return on capital %10.313.7 74.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,6366,164 26.5%   
Fx outflow Rs m4,3681,334 327.3%   
Net fx Rs m-2,7324,829 -56.6%   
CASH FLOW
From Operations Rs m-1,3041,231 -106.0%  
From Investments Rs m12,697-208 -6,101.5%  
From Financial Activity Rs m-301-595 50.5%  
Net Cashflow Rs m11,093427 2,597.3%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 51.8 0.3 17,266.7%  
Indian inst/Mut Fund % 18.2 3.4 536.9%  
FIIs % 1.0 3.9 25.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 37.0 78.6%  
Shareholders   28,591 30,437 93.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PFIZER  NATCO PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Scales 42,000 and Smallcaps Rebound: What Happens Next?(Podcast)

This week, the BSE Sensex crossed 42,000 level for the first time. While Nifty followed suit, hitting a record high of 12,377.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Jan 6, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

I Made a Killing in the Markets this Week... Here's How(Profit Hunter)

Jan 10, 2020

How we made a killing in the markets amidst geopolitical tension and war mongering.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jan 17, 2020 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - ALEMBIC PHARMA COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS